Source Date | Board Meeting Date | Details |
17-Apr-2025
|
24-Apr-2025
|
Inter alia, to consider and approve:- 1. To Approve the Letter of Offer (LOF) for the proposed Rights Issue of 49,19,04,000 Equity Shares of Re. 1/- each, aggregating to 4919.04 lakhs for shareholders of the Company. 2. Any other item with the permission of the Chair and Majority of Directors.
|
01-Apr-2025
|
07-Apr-2025
|
Rights Issue
|
10-Feb-2025
|
14-Feb-2025
|
Quarterly Results
|
17-Jan-2025
|
22-Jan-2025
|
Inter alia, to consider and approve:- (1) Raising funds by way of issue of fresh equity shares through Right Issue basis along-with other matter, if any, as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required. 2) Any other business with the permission of the Chair.
|
11-Nov-2024
|
14-Nov-2024
|
Quarterly Results
|
28-Aug-2024
|
04-Sep-2024
|
(Revised) Inter alia to consider the following:- 1. To Consider Acquisition of AirOWater Global Trading LLC, UAE:The Board will review the proposal to acquire a substantial stake in AirOWater Global Trading LLC, a pioneering entity in the production of the purest form of drinking water via Atmospheric Water Generators (AWGs). This technology, recognised as one of the most sustainable solutions to the pressing issue of global water scarcity, has successfully catered to diverse sectors including Government Institutions, Corporates, Hospitality chains, Supermarkets, Hospital chains, Educational institutions, and Community Centres. 2. To Consider issuing of Foreign Currency Convertible Bonds (FCCBs). 3. Any other business with the permission of the Chair.
|
27-Aug-2024
|
03-Sep-2024
|
Inter alia, to transact following business:- 1. Acquisition of a company, Airowater Global Trading LLC, UAE which is into Water Injectables for Pharma Production. 2. Consideration of issuing of Foreign Currency Convertible Bonds (FCCBs) 3. Any other business with the permission of the Chair
|
07-Aug-2024
|
14-Aug-2024
|
Quarterly Results (Revised)
|
18-Jul-2024
|
20-Jul-2024
|
Increase in Authorised Capital
|
15-Jul-2024
|
08-Aug-2024
|
Quarterly Results
|